https://www.prnewswire.com/news-releases/mirati-therapeutics-reports-second-quarter-2021-financial-results-and-recent-corporate-updates-301349737.html
Mirati Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the second quarter...
mirati therapeuticssecond quarter2021 financial
https://www.biospace.com/mirati-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-may-5-2023
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - May 5, 2023 -...
May 6, 2023 - Mirati Therapeutics, Inc. today announced that the company granted equity awards to 2 new employees with a grant date of May 1, 2023, as equity inducement...
https://www.biospace.com/mirati-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-jan-06-2023
Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Jan 06, 2023 -...
Jan 9, 2023 - Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced that the company granted equity awards to 6 new employees with a grant date of...